Helicobacter pylori - In vitro susceptibility to garlic (Allium sativum) extract

被引:93
作者
Sivam, GP
Lampe, JW
Ulness, B
Swanzy, SR
Potter, JD
机构
[1] FRED HUTCHINSON CANC RES CTR,CANC PREVENT RES PROGRAM,DIV PUBL HLTH SCI,SEATTLE,WA 98104
[2] UNIV WASHINGTON,MED CTR,DEPT LAB MED,DIV MICROBIOL,SEATTLE,WA 98195
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 1997年 / 27卷 / 02期
关键词
D O I
10.1080/01635589709514512
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer is the major cancer in the developing world and one of the top two worldwide. Helicobacter pylori is a bacterium implicated in the etiology of stomach cancer. The incidence of stomach cancer is tower in individuals and populations with high Allium vegetable intakes. Allium vegetables, particularly garlic, have antibiotic activity. Standard antibiotic regimens against H. pylori are frequently ineffective in high-risk populations. As parr of our study of the role of Allium vegetable intake on cancer prevention, we wished to investigate its antimicrobial activity against H. pylori. An aqueous extract of garlic cloves was standardized for its thiosulfinate concentration and tested for its antimicrobial activity on H. pylori grown on chocolate agar plates. Minimum inhibitory concentration was 40 mu g thiosulfinate per milliliter. Staphylococcus aureus tested under the same conditions was not susceptible to garlic extract tip to the maximum thiosulfinate concentration tested (160 mu g/ml). To our knowledge, this is the first report of H. pylori's susceptibility to garlic extract of known thiosulfinate concentration. It is plausible that the sensitivity of H. pylori to garlic extract at such low concentration may be related to the reported lower risk of stomach cancer in those with a high Allium vegetable intake. Furthermore, it may identify a strategy for a low-cost intervention, with few side effects, in populations at high risk for stomach cancer, particularly where antibiotic resistance and the risk of reinfection are high.
引用
收藏
页码:118 / 121
页数:4
相关论文
共 12 条
[1]   HELICOBACTER-PYLORI - ITS ROLE IN DISEASE [J].
BLASER, MJ .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (03) :386-393
[2]   DIFFICULTY IN ERADICATING HELICOBACTER-PYLORI IN A POPULATION AT HIGH-RISK FOR STOMACH-CANCER IN VENEZUELA [J].
BUIATTI, E ;
MUNOZ, N ;
VIVAS, J ;
CANO, E ;
PERAZA, S ;
CARILLO, E ;
CASTRO, D ;
SANCHEZ, V ;
ANDRADE, O ;
BENZ, M ;
DESANJOSE, S ;
OLIVER, W .
CANCER CAUSES & CONTROL, 1994, 5 (03) :249-254
[3]   A CASE-CONTROL STUDY OF GASTRIC-CANCER AND DIET IN ITALY [J].
BUIATTI, E ;
PALLI, D ;
DECARLI, A ;
AMADORI, D ;
AVELLINI, C ;
BIANCHI, S ;
BISERNI, R ;
CIPRIANI, F ;
COCCO, P ;
GIACOSA, A ;
MARUBINI, E ;
PUNTONI, R ;
VINDIGNI, C ;
FRAUMENI, J ;
BLOT, W .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (04) :611-616
[4]  
*EUR STUD GROUP, 1993, LANCET, V341, P1359
[5]   MEDICAL PROGRESS - GASTRIC-CARCINOMA [J].
FUCHS, CS ;
MAYER, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) :32-41
[6]  
HAN H, 1994, ANAL BIOCHEM, V225, P157
[7]   Lipid profile of Helicobacter spp: Presence of cholesteryl glucoside as a characteristic feature [J].
Haque, M ;
Hirai, Y ;
Yokota, K ;
Mori, N ;
Jahan, I ;
Ito, H ;
Hotta, H ;
Yano, I ;
Kanemasa, Y ;
Oguma, K .
JOURNAL OF BACTERIOLOGY, 1996, 178 (07) :2065-2070
[8]   LIPID ANALYSIS OF HELICOBACTER-PYLORI [J].
INAMOTO, Y ;
ARIYAMA, S ;
HAMANAKA, Y ;
OKITA, K ;
KANETA, Y ;
NAGATE, T ;
KONDOU, I ;
TAKEMOTO, T .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1993, 17 :S136-S139
[9]  
Lawson LD, 1996, GARLIC SCI THERAPEUT, P37
[10]  
Reuter HD, 1996, GARLIC SCI THERAPEUT, P162